AKCEA THERAPEUTICS, INC. 4 SEC Filings

Filed On	Filing
14 Oct 2020	Form 4: Ionis Pharmaceuticals Inc, 10% owner Bought 21,237,715 shares ($385M)
13 Oct 2020	Form 4: Price Michael Dennis, Chief Financial Officer Disposed of 50,000 shares (Tender Offer) ($908K) · Disposed of 300,000 Stock Option (right to buy) (Disposition to Issuer) ($1.01M)
13 Oct 2020	Form 4: Patterson Joshua F., General Counsel Disposed of 26,532 shares (Tender Offer) ($482K) · Disposed of 21,250 Stock Option (right to buy) (Disposition to Issuer) ($56.4K)
13 Oct 2020	Form 4: Jenne Kyle, Chief Commercial Officer Disposed of 52,012 shares (Tender Offer) ($944K) · Disposed of 224,325 Stock Option (right to buy) (Disposition to Issuer) ($1.24M)
13 Oct 2020	Form 4: Howarth Alex G., Chief Operating Officer Disposed of 66,800 shares (Tender Offer) ($1.21M) · Disposed of 334,200 Stock Option (right to buy) (Disposition to Issuer) ($247K)
13 Oct 2020	Form 4: Andrews William T., Chief Medical Officer Disposed of 37,500 shares (Tender Offer) ($681K) · Disposed of 250,000 Stock Option (right to buy) (Disposition to Issuer) ($1.22M)
13 Oct 2020	Form 4: McDevitt Damien, Director Disposed of 242,978 shares (Tender Offer) ($4.41M) · Disposed of 320,000 Stock Option (right to buy) (Disposition to Issuer) ($1.72M)
13 Oct 2020	Form 4: Yanni Barbara, Director Disposed of 26,400 Stock Option (right to buy) (Disposition to Issuer) ($53.1K)
13 Oct 2020	Form 4: Yang Michael J., Director Disposed of 26,400 Stock Option (right to buy) (Disposition to Issuer) ($53.1K)
13 Oct 2020	Form 4: Smith Sandford D, Director Disposed of 79,237 Stock Option (right to buy) (Disposition to Issuer) ($367K)
13 Oct 2020	Form 4: Salzman Amber, Director Disposed of 79,400 Stock Option (right to buy) (Disposition to Issuer) ($64.2K)
13 Oct 2020	Form 4: Klein Joseph Iii, Director Disposed of 26,400 Stock Option (right to buy) (Disposition to Issuer) ($53.1K)
13 Oct 2020	Form 4: Hochberg Elaine, Director Disposed of 79,237 Stock Option (right to buy) (Disposition to Issuer) ($367K)
13 Oct 2020	Form 4: Parshall B Lynne, Director Disposed of 26,400 Stock Option (right to buy) (Disposition to Issuer) ($53.1K)
24 Sep 2020	Form 4: Patterson Joshua F., General Counsel Sold 319 shares ($5.78K)
24 Sep 2020	Form 4: Jenne Kyle, Chief Commercial Officer Sold 720 shares ($13K)
24 Sep 2020	Form 4: McDevitt Damien, Director Sold 8,709 shares ($158K)
02 Sep 2020	Form 4: McDevitt Damien, Director Received 1,104 shares as a grant or award ($15.9K)
20 Jul 2020	Form 4: Patterson Joshua F., General Counsel Sold 263 shares ($3.29K)
10 Jul 2020	Form 4: Andrews William T., Chief Medical Officer Received 37,500 shares as a grant or award · Granted 250,000 Stock Option (right to buy)

Comments